STOCK TITAN

Elanco Animal Health (NYSE: ELAN) awards deferred stock units to company officer

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc company officer Rajeev A. Modi received a grant of 59.5056 deferred stock units on July 10, 2026 at a reference price of $24.82 per unit. Each unit represents the right to one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi directly holds 9,582.6368 deferred stock units.

Positive

  • None.

Negative

  • None.
Insider Modi Rajeev A.
Role SEE REMARKS
Type Security Shares Price Value
Grant/Award Deferred Stock Units F1, F2 59.5056 $24.82 $1K
Holdings After Transaction: Deferred Stock Units — 9,582.6368 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units granted 59.5056 units Grant of deferred stock units on July 10, 2026
Reference price per unit $24.82 Valuation price used for the July 10, 2026 deferred stock unit grant
Deferred stock units after grant 9,582.6368 units Total direct deferred stock unit holdings following the award
Deferred Stock Units financial
"Each deferred stock unit represents the right to receive one share of Company common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
cash equivalent financial
"represents the right to receive one share of Company common stock or the cash equivalent"
Executive Deferral and Stock Match Plan financial
"settle in cash or shares of Company common stock ... in accordance with Executive Deferral and Stock Match Plan"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Elanco (ELAN) report for Rajeev A. Modi?

Elanco reported that company officer Rajeev A. Modi received a grant of 59.5056 deferred stock units on July 10, 2026. These are compensation-related awards, not open-market purchases or sales, and are tied to the company’s Executive Deferral and Stock Match Plan.

How many deferred stock units were granted to Rajeev A. Modi at Elanco (ELAN)?

Rajeev A. Modi was granted 59.5056 deferred stock units linked to Elanco common stock. After this award, his direct holdings in deferred stock units increased to 9,582.6368 units, representing future rights to cash or shares rather than current ownership of common stock.

At what price were the Elanco (ELAN) deferred stock units valued in Modi's grant?

The deferred stock units granted to Rajeev A. Modi were valued at a reference price of $24.82 per unit. This price is used for award valuation purposes and does not indicate an open-market purchase transaction by the officer on that date.

What does a deferred stock unit represent for Elanco (ELAN)?

Each Elanco deferred stock unit represents the right to receive one share of common stock or the cash equivalent. Settlement occurs later, giving the holder future economic exposure rather than immediate stock ownership or voting rights like regular common shares.

When will Rajeev A. Modi's Elanco (ELAN) deferred stock units settle?

The deferred stock units will settle in cash or Elanco common stock after Modi’s employment terminates or during a specified future year. Settlement timing follows the terms of Elanco’s Executive Deferral and Stock Match Plan governing these deferred compensation awards.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modi Rajeev A.

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SEE REMARKS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)07/10/2026A59.5056 (2) (2)Common Stock59.5056$24.829,582.6368D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi07/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)